Assessing the Diagnostic Performance of a Smart Bra Using Temperature and Bioimpedance for Breast Cancer Detection: A...

Current screening protocols for breast malignancies often face significant limitations regarding sensitivity in younger populations. Dense tissue structures frequently obscure diagnostic clarity during standard radiological examinations. Interval cancers also remain difficult to identify using traditional imaging modalities alone. This gap motivated the development of non-invasive, wearable monitoring technologies. The PHI-BRA system integrates thermal and electrical sensing to provide frequent, longitudinal assessments. Prior research has shown that metabolic changes in tumor microenvironments often manifest as localized temperature variations. That uncertainty drove the need for a device capable of capturing these subtle physiological signals outside of clinical settings. No prior work had resolved the feasibility of deploying this specific multimodal wearable in a human cohort.

This study aimed to evaluate the feasibility and diagnostic performance of the PHI-BRA system in human subjects. Researchers sought to determine if the device could effectively differentiate between individuals with and without breast lesions. The team addressed the limitations of current screening methods, which often struggle with dense tissue and interval cancers. By combining thermal and electrical sensing, the authors investigated a novel approach to frequent breast monitoring. This work was motivated by the need for non-invasive, accessible screening alternatives for younger women. The study design focused on establishing a robust discrimination model using a calibration cohort. Investigators also intended to compare the device's output against standard mammography results. This research provides an initial assessment of the safety and clinical potential of the wearable platform.

Investigators performed a prospective feasibility study between March 2023 and February 2024. The research team utilized a calibration group of 15 subjects to establish the initial discrimination model. An analysis cohort consisting of 26 participants followed this phase to test the system. Half of the analysis group presented with confirmed breast lesions, while the remainder served as controls. Thermal and electrical signals were gathered directly from the wearable device during the sessions. Analysts applied receiver operating characteristic curves to determine the diagnostic efficacy of the collected data. Mammography served as the reference standard for all comparative assessments conducted throughout the trial. The team monitored all participants for potential adverse events to ensure the safety of the wearable technology.

The temperature-based model achieved an area under the receiver operating characteristic curve of 80.8% within the analysis cohort. Researchers calculated a sensitivity of 84.6% at the optimal threshold for this model. The specificity reached 76.9% during the same evaluation period. Exploratory bioimpedance analyses yielded high specificity but demonstrated lower sensitivity than the thermal measurements. Sensor contact stability emerged as the primary factor limiting the performance of the bioimpedance data. No adverse events occurred during the testing of the wearable system. The 95% confidence intervals for the temperature model sensitivity ranged from 61.5% to 100%. Specificity for the temperature model showed a 95% confidence interval between 53.8% and 100%.

This initial human investigation confirms the practical feasibility of utilizing wearable thermal monitoring for identifying breast lesions. The findings suggest that such systems are safe for patient use during preliminary testing phases. Authors propose that the device could function as a supportive tool alongside established screening programs. Future clinical validation remains necessary to refine the diagnostic accuracy of the multimodal platform. The data indicate that temperature-based models currently outperform bioimpedance metrics in this specific configuration. Researchers emphasize that sensor stability is a primary factor influencing the performance of electrical measurements. The study provides a foundation for developing more robust, non-invasive screening alternatives for diverse patient groups. These results highlight the potential for wearable technology to enhance early detection strategies in clinical practice.